Tandem Diabetes Care, Inc.
TNDM
$18.97
$0.794.35%
| Weiss Ratings | TNDM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | TNDM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | TNDM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.75 | |||
| Price History | TNDM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.73% | |||
| 30-Day Total Return | -48.74% | |||
| 60-Day Total Return | -41.92% | |||
| 90-Day Total Return | -39.53% | |||
| Year to Date Total Return | -47.07% | |||
| 1-Year Total Return | -32.25% | |||
| 2-Year Total Return | -55.40% | |||
| 3-Year Total Return | -81.38% | |||
| 5-Year Total Return | -60.49% | |||
| 52-Week High % Change | -66.14% | |||
| 52-Week Low % Change | 3.06% | |||
| Price | TNDM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $53.69 | |||
| 52-Week Low Price | $17.64 | |||
| 52-Week Low Price (Date) | Mar 10, 2025 | |||
| 52-Week High Price (Date) | May 31, 2024 | |||
| Valuation | TNDM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.21B | |||
| Enterprise Value | 1.25B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.47 | |||
| Earnings Per Share Growth | -57.18% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.28 | |||
| Price/Book (Q) | 4.58 | |||
| Enterprise Value/Revenue (TTM) | 1.33 | |||
| Price | $18.97 | |||
| Enterprise Value/EBITDA (TTM) | -15.13 | |||
| Enterprise Value/EBIT | -12.60 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | TNDM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 66.16M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TNDM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 858 366 6900 | |||
| Address | 12400 High Bluff Drive San Diego, CA 92130 | |||
| Website | www.tandemdiabetes.com | |||
| Country | United States | |||
| Year Founded | 2006 | |||
| Profitability | TNDM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -10.54% | |||
| Profit Margin | -10.21% | |||
| Management Effectiveness | TNDM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -6.45% | |||
| Return on Equity | -- | |||
| Income Statement | TNDM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 940.20M | |||
| Total Revenue (TTM) | 940.20M | |||
| Revenue Per Share | $14.21 | |||
| Gross Profit (TTM) | 489.57M | |||
| EBITDA (TTM) | -82.52M | |||
| EBIT (TTM) | -99.13M | |||
| Net Income (TTM) | -96.03M | |||
| Net Income Avl. to Common (TTM) | -96.03M | |||
| Total Revenue Growth (Q YOY) | 43.62% | |||
| Earnings Growth (Q YOY) | 102.52% | |||
| EPS Diluted (TTM) | -1.47 | |||
| EPS Diluted Growth (Q YOY) | 102.48% | |||
| Balance Sheet | TNDM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 438.33M | |||
| Cash Per Share (Q) | $6.63 | |||
| Total Current Assets (Q) | 724.49M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 263.10M | |||
| Current Ratio (Q) | 2.933 | |||
| Book Value Per Share (Q) | $3.97 | |||
| Total Assets (Q) | 967.66M | |||
| Total Current Liabilities (Q) | 247.05M | |||
| Total Debt (Q) | 478.37M | |||
| Total Liabilities (Q) | 704.56M | |||
| Total Common Equity (Q) | 263.10M | |||
| Cash Flow | TNDM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -23.48M | |||
| Cash from Financing (TTM) | 8.37M | |||
| Net Change in Cash (TTM) | 10.37M | |||
| Levered Free Cash Flow (TTM) | 27.71M | |||
| Cash from Operations (TTM) | 24.23M | |||
